2‐chloro‐2′‐deoxyadenosine in the treatment of Sjögren's syndrome–associated B cell lymphoproliferation
- 9 August 2002
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (8) , 2248-2249
- https://doi.org/10.1002/art.10434
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Malignant lymphoma in primary Sj gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj gren's syndromeArthritis & Rheumatism, 1999
- A pilot study of 2-chloro-2?-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritisArthritis & Rheumatism, 1998
- Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross‐reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndromeArthritis & Rheumatism, 1996
- 2-Chlorodeoxyadenosine: A Newer Purine Analog Active in the Treatment of Indolent Lymphoid MalignanciesAnnals of Internal Medicine, 1994